Browsing: Health

(Reuters) -Mikael Dolsten, Pfizer’s former research and development ​chief, has withdrawn his candidacy for ‌Novo Nordisk’s board, citing personal reasons,…

A higher Medicare premium set to go into effect in 2026 will push the monthly charge above $200 for the…

Paired with high-deductible healthcare plans, health savings accounts help ease healthcare costs. HSAs are a triple tax-advantaged vehicle in the…

By Puyaan Singh Jan 12 (Reuters) – Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic ​interest in…

SHANGHAI, Jan 27 (Reuters) – China’s medicine regulator has ordered a halt to ​the import, sale and usage of ‌a…

By Byron Kaye SYDNEY, Feb 3 (Reuters) – Sleep-breathing device maker ResMed plans to take global a doctor education program…

COPENHAGEN, Feb 9 (Reuters) – Novo Nordisk’s Frankfurt-listed shares rose 4.5% on Monday after telehealth ​firm Hims & Hers reversed…

Feb 10 (Reuters) – CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped…

Feb 19 (Reuters) – Cassava Sciences said on Thursday the U.S. Department of Justice ‌had ended its probe into the…

Feb 23 (Reuters) – Novo Nordisk’s next-generation weight-loss drug CagriSema was less effective than Eli Lilly’s Zepbound in a head-to-head…